Moonlake Immunotherapeutics · NASDAQ:MLTX

Reich Kristian sold 43,700 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 20, 2026 · Filed Jul 21, 2026

On Jul 20, 2026, Reich Kristian (Chief Scientific Officer) sold 43,700 Moonlake Immunotherapeutics shares at US$20.09 for US$878K under a trading plan, leaving 2,764,746 shares. Filed Jul 21, 2026 (Form 4).

Sold
43,700 shares
Price
US$20.09
Value
US$878K
Holding after
2,764,746 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 20, 2026Class A ordinary shares, par value $0.0001 per shareSale43,700US$20.092,764,746Indirect

Source

View original at SEC

Related